Lexaria Bioscience Warrant
LEXXW
LEXXW was delisted on the 13th of January, 2026.
4 hedge funds and large institutions have $2.58M invested in Lexaria Bioscience Warrant in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
22% more capital invested
Capital invested by funds: $2.11M → $2.58M (+$470K)
0% more funds holding
Funds holding: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$287K |
Top Sellers
LEXXW Hedge Fund Activity: Q2 2021 in Review
4 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Lexaria Bioscience Warrant (LEXXW) for Q2 2021, worth a combined $2.58M — up 22% from $2.11M a quarter earlier.
Fund positioning in LEXXW was balanced in Q2 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $287K.
- 4 institutional investors held Lexaria Bioscience Warrant (LEXXW) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $2.58M of Lexaria Bioscience Warrant stock for Q2 2021, up 22% quarter-over-quarter.
- 0 funds opened new Lexaria Bioscience Warrant positions in Q2 2021 and 0 closed out.
- The largest Lexaria Bioscience Warrant buyer in Q2 2021 was Sabby Management, an estimated $287K added.
Based on aggregated 13F filings for Q2 2021.